Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation.

Gembitsky DS, Lawlor K, Jacovina A, Yaneva M, Tempst P.

Mol Cell Proteomics. 2004 Nov;3(11):1102-18. Epub 2004 Sep 8.

2.

Rapid detection of phosphotyrosine proteins by flow cytometric analysis in Bcr-Abl-positive cells.

Desplat V, Lagarde V, Belloc F, Chollet C, Leguay T, Pasquet JM, Praloran V, Mahon FX.

Cytometry A. 2004 Nov;62(1):35-45.

3.

Profiling the global tyrosine phosphorylation state.

Machida K, Mayer BJ, Nollau P.

Mol Cell Proteomics. 2003 Apr;2(4):215-33. Epub 2003 May 17. Review.

4.

Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.

Koch A, Scherr M, Breyer B, Mancini A, Kardinal C, Battmer K, Eder M, Tamura T.

Oncogene. 2008 Aug 7;27(34):4678-89. doi: 10.1038/onc.2008.107. Epub 2008 Apr 21.

PMID:
18427551
5.

Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway.

Steen H, Kuster B, Fernandez M, Pandey A, Mann M.

J Biol Chem. 2002 Jan 11;277(2):1031-9. Epub 2001 Oct 30.

6.

Immunoaffinity enrichments followed by mass spectrometric detection for studying global protein tyrosine phosphorylation.

Bergström Lind S, Molin M, Savitski MM, Emilsson L, Aström J, Hedberg L, Adams C, Nielsen ML, Engström A, Elfineh L, Andersson E, Zubarev RA, Pettersson U.

J Proteome Res. 2008 Jul;7(7):2897-910. doi: 10.1021/pr8000546. Epub 2008 Jun 11.

PMID:
18543961
7.

Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.

Huang L, Watanabe M, Chikamori M, Kido Y, Yamamoto T, Shibuya M, Gotoh N, Tsuchida N.

Oncogene. 2006 Oct 19;25(49):6457-66. Epub 2006 May 15.

PMID:
16702953
8.

Tyrosine phosphoproteomics and identification of substrates of protein tyrosine phosphatase dPTP61F in Drosophila S2 cells by mass spectrometry-based substrate trapping strategy.

Chang YC, Lin SY, Liang SY, Pan KT, Chou CC, Chen CH, Liao CL, Khoo KH, Meng TC.

J Proteome Res. 2008 Mar;7(3):1055-66. doi: 10.1021/pr700801p. Epub 2008 Feb 19.

PMID:
18281928
9.

Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.

Vazquez-Martin A, Colomer R, Brunet J, Lupu R, Menendez JA.

Cell Prolif. 2008 Feb;41(1):59-85. doi: 10.1111/j.1365-2184.2007.00498.x.

PMID:
18211286
10.

Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC).

Amanchy R, Kalume DE, Iwahori A, Zhong J, Pandey A.

J Proteome Res. 2005 Sep-Oct;4(5):1661-71.

PMID:
16212419
11.

Global effects of BCR/ABL and TEL/PDGFRbeta expression on the proteome and phosphoproteome: identification of the Rho pathway as a target of BCR/ABL.

Unwin RD, Sternberg DW, Lu Y, Pierce A, Gilliland DG, Whetton AD.

J Biol Chem. 2005 Feb 25;280(8):6316-26. Epub 2004 Nov 29.

12.

Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics.

Blagoev B, Ong SE, Kratchmarova I, Mann M.

Nat Biotechnol. 2004 Sep;22(9):1139-45. Epub 2004 Aug 15.

PMID:
15314609
13.

Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.

Koyama N, Koschmieder S, Tyagi S, Portero-Robles I, Chromic J, Myloch S, Nürnberger H, Rossmanith T, Hofmann WK, Hoelzer D, Ottmann OG.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2025-31.

14.

Quantitative mass spectrometry to investigate epidermal growth factor receptor phosphorylation dynamics.

Schuchardt S, Borlak J.

Mass Spectrom Rev. 2008 Jan-Feb;27(1):51-65. Review.

PMID:
18023079
15.

Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.

Derkinderen P, Scales TM, Hanger DP, Leung KY, Byers HL, Ward MA, Lenz C, Price C, Bird IN, Perera T, Kellie S, Williamson R, Noble W, Van Etten RA, Leroy K, Brion JP, Reynolds CH, Anderton BH.

J Neurosci. 2005 Jul 13;25(28):6584-93.

16.

Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.

Zhang Y, Wolf-Yadlin A, Ross PL, Pappin DJ, Rush J, Lauffenburger DA, White FM.

Mol Cell Proteomics. 2005 Sep;4(9):1240-50. Epub 2005 Jun 11.

17.

Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M.

Cell. 2006 Nov 3;127(3):635-48.

18.
19.

Inhibitors of protein tyrosine phosphorylation: preliminary assessment of activity by time-resolved fluorescence.

Amir-Zaltsman Y, Mazor O, Gayer B, Scherz A, Salomon Y, Kohen F.

Luminescence. 2000 Nov-Dec;15(6):377-80.

PMID:
11114114
20.

Src homology 2 domain-based high throughput assays for profiling downstream molecules in receptor tyrosine kinase pathways.

Yaoi T, Chamnongpol S, Jiang X, Li X.

Mol Cell Proteomics. 2006 May;5(5):959-68. Epub 2006 Feb 13.

Supplemental Content

Support Center